1. From the ICRF Cancer Medicine Research Unit, University of Leeds, and the Department of Surgery, University of Edinburgh, United Kingdom; the Institute of BioChemical Physics, Moscow, Russia; the Frederick Cancer and Development Center, National Cancer Institute, Frederick, and the Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland; the Computer Center of the Russian Academy of Sciences, Moscow, Russia; the Institute for Cancer Research, University of Trondheim, Norway; and the...